Dr. Najah Abi-Gerges, VP of Research & Development at AnaBios, presented an overview of myosin modulation for heart therapies at the 2023 Translational Research Conference in San Diego. Dr. Abi-Gerges also discussed the procurement of normal and diseased human hearts from consented donors, ex vivo human cardiac drug discovery models and anti-arrhythmic therapies.

To learn more about AnaBios and our superior quality human tissue, please visit http://www.anabios.com.